Koike Sanso Kogyo Co.,Ltd. (TYO:6137)

Sage Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	16,984	13,581	14,993	12,751	11,217
Short-Term Investments	-	3,000	-	-	325
Cash & Short-Term Investments	16,984	16,581	14,993	12,751	11,542
Cash Growth	2.43%	10.59%	17.58%	10.47%	16.29%
Receivables	14,474	14,735	13,059	12,660	11,531
Inventory	8,990	8,693	8,701	7,518	6,184
Other Current Assets	1,238	1,238	810	684	692
Total Current Assets	41,686	41,247	37,563	33,613	29,949
Property, Plant & Equipment	13,547	12,946	12,657	13,047	13,597
Long-Term Investments	18,680	18,547	14,081	12,741	12,383
Goodwill	1	8	16	23	33
Other Intangible Assets	734	673	496	283	185
Long-Term Deferred Tax Assets	86	53	120	227	67
Other Long-Term Assets	1	2	1	1	1
Total Assets	74,735	73,476	64,934	59,935	56,215
Accounts Payable	10,938	11,784	10,944	9,603	8,654
Accrued Expenses	1,119	1,003	792	609	450
Short-Term Debt	5,037	4,840	4,894	4,432	4,550
Current Portion of Long-Term Debt	268	413	420	469	528
Current Portion of Leases	668	549	501	585	686
Current Income Taxes Payable	945	905	860	536	281
Other Current Liabilities	3,590	4,747	4,863	3,854	2,432
Total Current Liabilities	22,565	24,241	23,274	20,088	17,581
Long-Term Debt	548	816	1,267	1,721	2,117
Long-Term Leases	711	628	465	554	724
Long-Term Deferred Tax Liabilities	4,664	4,757	3,211	3,235	3,269
Other Long-Term Liabilities	376	371	374	292	275
Total Liabilities	29,165	31,094	28,856	26,244	24,307
Common Stock	4,028	4,028	4,028	4,028	4,028
Additional Paid-In Capital	2,105	2,016	2,001	2,332	2,347
Retained Earnings	27,956	25,165	22,661	20,847	20,173
Treasury Stock	-694	-722	-760	-814	-881
Comprehensive Income & Other	9,161	8,858	5,282	4,391	3,770
Total Common Equity	42,556	39,345	33,212	30,784	29,437
Minority Interest	3,014	3,037	2,866	2,907	2,471
Shareholders' Equity	45,570	42,382	36,078	33,691	31,908
Total Liabilities & Equity	74,735	73,476	64,934	59,935	56,215
Total Debt	7,232	7,246	7,547	7,761	8,605
Net Cash (Debt)	9,752	9,335	7,446	4,990	2,937
Net Cash Growth	4.47%	25.37%	49.22%	69.90%	3.09%
Net Cash Per Share	462.93	444.63	356.27	239.90	141.58
Filing Date Shares Outstanding	21.08	21.03	20.95	20.84	20.97
Total Common Shares Outstanding	21.08	21.03	20.95	20.84	20.75
Working Capital	19,121	17,006	14,289	13,525	12,368
Book Value Per Share	2018.65	1871.32	1585.44	1477.18	1418.33
Tangible Book Value	41,821	38,664	32,700	30,478	29,219
Tangible Book Value Per Share	1983.79	1838.93	1561.00	1462.50	1407.82
Order Backlog	7,101	7,579	7,936	5,743	3,207

Source: S&P Global Market Intelligence. Standard template. Financial Sources.